Analysts' ratings for 3M MMM over the last quarter vary from bullish to bearish, as provided by 15 analysts.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 3 | 7 | 4 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 1 | 3 | 1 | 0 |
| 2M Ago | 0 | 2 | 4 | 2 | 0 |
| 3M Ago | 0 | 0 | 0 | 1 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $101.07, with a high estimate of $126.00 and a low estimate of $78.00. A 0.32% drop is evident in the current average compared to the previous average price target of $101.39.
Investigating Analyst Ratings: An Elaborate Study
A clear picture of 3M's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Wesley Brooks | HSBC | Raises | Buy | $115.00 | $91.13 |
| Andrew Kaplowitz | Citigroup | Raises | Neutral | $100.00 | $98.00 |
| Deane Dray | RBC Capital | Raises | Underperform | $87.00 | $78.00 |
| Damian Karas | UBS | Raises | Neutral | $100.00 | $98.00 |
| Stephen Tusa | JP Morgan | Raises | Overweight | $111.00 | $110.00 |
| Stephen Tusa | JP Morgan | Lowers | Neutral | $110.00 | $118.00 |
| Andrew Kaplowitz | Citigroup | Raises | Neutral | $98.00 | $95.31 |
| Deane Dray | RBC Capital | Lowers | Underperform | $78.00 | $84.00 |
| Julian Mitchell | Barclays | Lowers | Overweight | $107.00 | $126.00 |
| Andrew Obin | B of A Securities | Lowers | Neutral | $100.00 | $110.00 |
| Brett Linzey | Mizuho | Maintains | Neutral | $105.00 | $105.00 |
| Deane Dray | RBC Capital | Maintains | Underperform | $84.00 | - |
| Julian Mitchell | Barclays | Raises | Overweight | $126.00 | $111.00 |
| Julian Mitchell | Barclays | Raises | Equal-Weight | $111.00 | $110.00 |
| Deane Dray | RBC Capital | Lowers | Underperform | $84.00 | $85.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to 3M. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of 3M compared to the broader market.
- Price Targets: Understanding forecasts, analysts offer estimates for 3M's future value. Examining the current and prior targets provides insight into analysts' changing expectations.
Capture valuable insights into 3M's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on 3M analyst ratings.
Delving into 3M's Background
3M is a multinational conglomerate that has operated since 1902, when it was known as Minnesota Mining and Manufacturing. The company is well known for its research and development laboratory and it leverages its science and technology across multiple product categories. As of the second quarter of 2024, 3M is organized across three business segments: safety and industrial, transportation and electronics, and consumer. Nearly 50% of the company's revenue comes from outside the Americas, with the safety and industrial segment constituting a plurality of net sales. Many of the company's tens of thousands of products touch and concern a variety of consumers and end markets.
Financial Insights: 3M
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Negative Revenue Trend: Examining 3M's financials over 3 months reveals challenges. As of 31 March, 2024, the company experienced a decline of approximately -0.35% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: 3M's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 11.6%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): 3M's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 19.19%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): 3M's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.75%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 4.55, caution is advised due to increased financial risk.
Analyst Ratings: What Are They?
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
